<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33198383</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>05</Day></DateCompleted><DateRevised><Year>2021</Year><Month>04</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>22</Issue><PubDate><Year>2020</Year><Month>Nov</Month><Day>12</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>A Novel HGF/SF Receptor (MET) Agonist Transiently Delays the Disease Progression in an Amyotrophic Lateral Sclerosis Mouse Model by Promoting Neuronal Survival and Dampening the Immune Dysregulation.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">8542</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms21228542</ELocationID><Abstract><AbstractText>Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease with no effective treatment. The Hepatocyte Growth Factor/Scatter Factor (HGF/SF), through its receptor MET, is one of the most potent survival-promoting factors for motor neurons (MN) and is known as a modulator of immune cell function. We recently developed a novel recombinant MET agonist optimized for therapy, designated K1K1. K1K1 was ten times more potent than HGF/SF in preventing MN loss in an in vitro model of ALS. Treatments with K1K1 delayed the onset of muscular impairment and reduced MN loss and skeletal muscle denervation of superoxide dismutase 1 G93A (SOD1G93A) mice. This effect was associated with increased levels of phospho-extracellular signal-related kinase (pERK) in the spinal cord and sciatic nerves and the activation of non-myelinating Schwann cells. Moreover, reduced activated microglia and astroglia, lower T cells infiltration and increased interleukin 4 (IL4) levels were found in the lumbar spinal cord of K1K1 treated mice. K1K1 treatment also prevented the infiltration of T cells in skeletal muscle of SOD1G93A mice. All these protective effects were lost on long-term treatment suggesting a mechanism of drug tolerance. These data provide a rational justification for further exploring the long-term loss of K1K1 efficacy in the perspective of providing a potential treatment for ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vallarola</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-7600-8058</Identifier><AffiliationInfo><Affiliation>Laboratory of Molecular Neurobiology, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tortarolo</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Neurobiology, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Gioia</LastName><ForeName>Roberta</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Neurobiology, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iamele</LastName><ForeName>Luisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Immunology and General Pathology Unit, Department of Molecular Medicine, Universit&#xe0; di Pavia, 27100 Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Jonge</LastName><ForeName>Hugo</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Immunology and General Pathology Unit, Department of Molecular Medicine, Universit&#xe0; di Pavia, 27100 Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Nola</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bovio</LastName><ForeName>Enrica</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-7401-5622</Identifier><AffiliationInfo><Affiliation>Immunology and General Pathology Unit, Department of Molecular Medicine, Universit&#xe0; di Pavia, 27100 Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pasetto</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Laboratory of Translational Biomarkers, Department of Biochemistry and Molecular Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonetto</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Laboratory of Translational Biomarkers, Department of Biochemistry and Molecular Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Freschi</LastName><ForeName>Mattia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Neurobiology, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bendotti</LastName><ForeName>Caterina</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-1055-1271</Identifier><AffiliationInfo><Affiliation>Laboratory of Molecular Neurobiology, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gherardi</LastName><ForeName>Ermanno</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Immunology and General Pathology Unit, Department of Molecular Medicine, Universit&#xe0; di Pavia, 27100 Pavia, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>SFMET-ALS</GrantID><Agency>AriSLA</Agency><Country/></Grant><Grant><GrantID>2015-0023</GrantID><Agency>Regione Lombardia</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C066855">HGF protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C553307">HGF protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008024">Ligands</NameOfSubstance></Chemical><Chemical><RegistryNumber>207137-56-2</RegistryNumber><NameOfSubstance UI="D015847">Interleukin-4</NameOfSubstance></Chemical><Chemical><RegistryNumber>67256-21-7</RegistryNumber><NameOfSubstance UI="D017228">Hepatocyte Growth Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.24</RegistryNumber><NameOfSubstance UI="D048049">Extracellular Signal-Regulated MAP Kinases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001522" MajorTopicYN="N">Behavior, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018920" MajorTopicYN="N">Coculture Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004285" MajorTopicYN="N">Dogs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D048049" MajorTopicYN="N">Extracellular Signal-Regulated MAP Kinases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005911" MajorTopicYN="N">Gliosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017228" MajorTopicYN="N">Hepatocyte Growth Factor</DescriptorName><QualifierName UI="Q000819" MajorTopicYN="Y">agonists</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007107" MajorTopicYN="Y">Immune System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015847" MajorTopicYN="N">Interleukin-4</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018082" MajorTopicYN="N">Kringles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008024" MajorTopicYN="N">Ligands</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061985" MajorTopicYN="N">Madin Darby Canine Kidney Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="Y">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012583" MajorTopicYN="N">Schwann Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013601" MajorTopicYN="N">T-Lymphocytes</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">HGF/SF</Keyword><Keyword MajorTopicYN="N">MET</Keyword><Keyword MajorTopicYN="N">SOD1G93A mice</Keyword><Keyword MajorTopicYN="N">T cells</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">motor neurons</Keyword><Keyword MajorTopicYN="N">pERK</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>11</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>17</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33198383</ArticleId><ArticleId IdType="pmc">PMC7696450</ArticleId><ArticleId IdType="doi">10.3390/ijms21228542</ArticleId><ArticleId IdType="pii">ijms21228542</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brown R.H., Al-Chalabi A. Amyotrophic Lateral Sclerosis. N. Engl. J. Med. 2017;377:162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejzini R., Flynn L.L., Pitout I.L., Fletcher S., Wilton S.D., Akkari P.A. ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now? Front. Neurosci. 2019;13:1310. doi: 10.3389/fnins.2019.01310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01310</ArticleId><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T., Robberecht W. Neuroinflammation in amyotrophic lateral sclerosis: Role of glial activation in motor neuron disease. Lancet Neurol. 2011;10:253&#x2013;263. doi: 10.1016/S1474-4422(11)70015-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(11)70015-1</ArticleId><ArticleId IdType="pubmed">21349440</ArticleId></ArticleIdList></Reference><Reference><Citation>Trias E., Kovacs M., King P.H., Si Y., Kwon Y., Varela V., Ibarburu S., Moura I.C., Hermine O., Beckman J.S., et al. Schwann cells orchestrate peripheral nerve inflammation through the expression of CSF1, IL-34, and SCF in amyotrophic lateral sclerosis. Glia. 2020;68:1165&#x2013;1181. doi: 10.1002/glia.23768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23768</ArticleId><ArticleId IdType="pmc">PMC7269115</ArticleId><ArticleId IdType="pubmed">31859421</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowerman M., Vincent T., Scamps F., Perrin F.E., Camu W., Raoul C. Neuroimmunity dynamics and the development of therapeutic strategies for amyotrophic lateral sclerosis. Front. Cell Neurosci. 2013;7:214. doi: 10.3389/fncel.2013.00214.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2013.00214</ArticleId><ArticleId IdType="pmc">PMC3833095</ArticleId><ArticleId IdType="pubmed">24312006</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W., Beers D.R., Appel S.H. Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis. J. Neuroimmune Pharmacol. 2013;8:888&#x2013;899. doi: 10.1007/s11481-013-9489-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-013-9489-x</ArticleId><ArticleId IdType="pmc">PMC4126425</ArticleId><ArticleId IdType="pubmed">23881705</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C., Watts M.E., Rubin L.L. MAP4K4 Activation Mediates Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis. Cell Rep. 2019;26:1143&#x2013;1156. doi: 10.1016/j.celrep.2019.01.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.01.019</ArticleId><ArticleId IdType="pubmed">30699345</ArticleId></ArticleIdList></Reference><Reference><Citation>Peviani M., Tortarolo M., Battaglia E., Piva R., Bendotti C. Specific induction of Akt3 in spinal cord motor neurons is neuroprotective in a mouse model of familial amyotrophic lateral sclerosis. Mol. Neurobiol. 2014;49:136&#x2013;148. doi: 10.1007/s12035-013-8507-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-013-8507-6</ArticleId><ArticleId IdType="pubmed">23873136</ArticleId></ArticleIdList></Reference><Reference><Citation>Ionescu A., Gradus T., Altman T., Maimon R., Saraf Avraham N., Geva M., Hayden M., Perlson E. Targeting the Sigma-1 Receptor via Pridopidine Ameliorates Central Features of ALS Pathology in a SOD1 G93A Model. Cell Death Disease. 2019;10:1&#x2013;19. doi: 10.1038/s41419-019-1451-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-019-1451-2</ArticleId><ArticleId IdType="pmc">PMC6397200</ArticleId><ArticleId IdType="pubmed">30824685</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers D.R., Appel S.H. Immune dysregulation in amyotrophic lateral sclerosis: Mechanisms and emerging therapies. Lancet Neurol. 2019;18:211&#x2013;220. doi: 10.1016/S1474-4422(18)30394-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30394-6</ArticleId><ArticleId IdType="pubmed">30663610</ArticleId></ArticleIdList></Reference><Reference><Citation>Maina F., Hilton M.C., Ponzetto C., Davies A.M., Klein R. Met receptor signaling is required for sensory nerve development and HGF promotes axonal growth and survival of sensory neurons. Genes Dev. 1997;11:3341&#x2013;3350. doi: 10.1101/gad.11.24.3341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.11.24.3341</ArticleId><ArticleId IdType="pmc">PMC316818</ArticleId><ArticleId IdType="pubmed">9407027</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebens A., Brose K., Leonardo E.D., Hanson M.G., Jr., Bladt F., Birchmeier C., Barres B.A., Tessier-Lavigne M. Hepatocyte Growth Factor/Scatter Factor Is an Axonal Chemoattractant and a Neurotrophic Factor for Spinal Motor Neurons. Neuron. 1996;17:1157&#x2013;1172. doi: 10.1016/S0896-6273(00)80247-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(00)80247-0</ArticleId><ArticleId IdType="pubmed">8982163</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato S., Funakoshi H., Nakamura T., Kato M., Nakano I., Hirano A., Ohama E. Expression of hepatocyte growth factor and c-Met in the anterior horn cells of the spinal cord in the patients with amyotrophic lateral sclerosis (ALS): Immunohistochemical studies on sporadic ALS and familial ALS with superoxide dismutase 1 gene mutation. Acta Neuropathol. 2003;106:112&#x2013;120. doi: 10.1007/s00401-003-0708-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-003-0708-z</ArticleId><ArticleId IdType="pubmed">12707786</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishigaki A., Aoki M., Nagai M., Warita H., Kato S., Kato M., Nakamura T., Funakoshi H., Itoyama Y. Intrathecal Delivery of Hepatocyte Growth Factor From Amyotrophic Lateral Sclerosis Onset Suppresses Disease Progression in Rat Amyotrophic Lateral Sclerosis Model. J. Neuropathol. Exp. Neurol. 2007;66:1037&#x2013;1044. doi: 10.1097/nen.0b013e318159886b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/nen.0b013e318159886b</ArticleId><ArticleId IdType="pubmed">17984685</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S.H., Kim S., Lee N., Lee J., Yu S.S., Kim J.H., Kim S. Intrathecal delivery of recombinant AAV1 encoding hepatocyte growth factor improves motor functions and protects neuromuscular system in the nerve crush and SOD1-G93A transgenic mouse models. Acta Neuropathol. Commun. 2019;7:96. doi: 10.1186/s40478-019-0737-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0737-z</ArticleId><ArticleId IdType="pmc">PMC6563368</ArticleId><ArticleId IdType="pubmed">31189468</ArticleId></ArticleIdList></Reference><Reference><Citation>Sufit R.L., Ajroud-Driss S., Casey P., Kessler J.A. Open label study to assess the safety of VM202 in subjects with amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Frontotemporal Degener. 2017;18:269&#x2013;278. doi: 10.1080/21678421.2016.1259334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1259334</ArticleId><ArticleId IdType="pubmed">28166654</ArticleId></ArticleIdList></Reference><Reference><Citation>Warita H., Kato M., Asada R., Yamashita A., Hayata D., Adachi K., Aoki M. Safety, Tolerability, and Pharmacodynamics of Intrathecal Injection of Recombinant Human HGF (KP-100) in Subjects With Amyotrophic Lateral Sclerosis: A Phase I Trial. J. Clin. Pharmacol. 2019;59:677&#x2013;687. doi: 10.1002/jcph.1355.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcph.1355</ArticleId><ArticleId IdType="pubmed">30536581</ArticleId></ArticleIdList></Reference><Reference><Citation>Gherardi E., Gray J., Stoker M., Perryman M., Furlong R. Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movement. Proc. Natl. Acad. Sci. USA. 1989;86:5844&#x2013;5848. doi: 10.1073/pnas.86.15.5844.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.86.15.5844</ArticleId><ArticleId IdType="pmc">PMC297727</ArticleId><ArticleId IdType="pubmed">2527367</ArticleId></ArticleIdList></Reference><Reference><Citation>Leclercq B., de Nola G., Mougel A., Dezitter-Tarron S., Simonneau C., Forneris F., Adriaenssens E., Drobecq H., Gherardi E., Melnyk O., et al. A minimal hepatocyte growth factor mimic acting as a powerful agonist of the MET receptor tyrosine kinase for regeneration of epithelial tissues and organs. BioRxiv. 2020 doi: 10.1101/2020.07.20.212654.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.07.20.212654</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonneau C., Leclercq B., Mougel A., Adriaenssens E., Paquet C., Raibaut L., Ollivier N., Drobecq H., Marcoux J., Cianf&#xe9;rani S., et al. Semi-synthesis of a HGF/SF kringle one (K1) domain scaffold generates a potent in vivo MET receptor agonist. Chem. Sci. 2015;6:2110&#x2013;2121. doi: 10.1039/C4SC03856H.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C4SC03856H</ArticleId><ArticleId IdType="pmc">PMC5496502</ArticleId><ArticleId IdType="pubmed">28717459</ArticleId></ArticleIdList></Reference><Reference><Citation>Tortarolo M., Vallarola A., Lidonnici D., Battaglia E., Gensano F., Spaltro G., Fiordaliso F., Corbelli A., Garetto S., Martini E., et al. Lack of TNF-alpha receptor type 2 protects motor neurons in a cellular model of amyotrophic lateral sclerosis and in mutant SOD1 mice but does not affect disease progression. J. Neurochem. 2015;135:109&#x2013;124. doi: 10.1111/jnc.13154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13154</ArticleId><ArticleId IdType="pubmed">25940956</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallarola A., Sironi F., Tortarolo M., Gatto N., De Gioia R., Pasetto L., De Paola M., Mariani A., Ghosh S., Watson R., et al. RNS60 exerts therapeutic effects in the SOD1 ALS mouse model through protective glia and peripheral nerve rescue. J. Neuroinflamm. 2018;15:65. doi: 10.1186/s12974-018-1101-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-018-1101-0</ArticleId><ArticleId IdType="pmc">PMC5833072</ArticleId><ArticleId IdType="pubmed">29495962</ArticleId></ArticleIdList></Reference><Reference><Citation>Napoli I., Noon L.A., Ribeiro S., Kerai A.P., Parrinello S., Rosenberg L.H., Collins M.J., Harrisingh M.C., White I.J., Woodhoo A., et al. A central role for the ERK-signaling pathway in controlling Schwann cell plasticity and peripheral nerve regeneration in vivo. Neuron. 2012;73:729&#x2013;742. doi: 10.1016/j.neuron.2011.11.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.11.031</ArticleId><ArticleId IdType="pubmed">22365547</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardo G., Trolese M.C., Verderio M., Mariani A., de Paola M., Riva N., Dina G., Panini N., Erba E., Quattrini A., et al. Counteracting roles of MHCI and CD8+ T cells in the peripheral and central nervous system of ALS SOD1G93A mice. Mol. Neurodegener. 2018;13:42. doi: 10.1186/s13024-018-0271-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-018-0271-7</ArticleId><ArticleId IdType="pmc">PMC6085701</ArticleId><ArticleId IdType="pubmed">30092791</ArticleId></ArticleIdList></Reference><Reference><Citation>Triolo D., Dina G., Lorenzetti I., Malaguti M., Morana P., Del Carro U., Comi G., Messing A., Quattrini A., Previtali S.C. Loss of glial fibrillary acidic protein (GFAP) impairs Schwann cell proliferation and delays nerve regeneration after damage. J. Cell Sci. 2006;119:3981&#x2013;3993. doi: 10.1242/jcs.03168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.03168</ArticleId><ArticleId IdType="pubmed">16988027</ArticleId></ArticleIdList></Reference><Reference><Citation>Benkhoucha M., Santiago-Raber M.-L., Schneiter G., Chofflon M., Funakoshi H., Nakamura T., Lalive P.H. Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25+Foxp3+ regulatory T cells. Proc. Natl. Acad. Sci. USA. 2010;107:6424&#x2013;6429. doi: 10.1073/pnas.0912437107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0912437107</ArticleId><ArticleId IdType="pmc">PMC2851995</ArticleId><ArticleId IdType="pubmed">20332205</ArticleId></ArticleIdList></Reference><Reference><Citation>Benkhoucha M., Molnarfi N., Schneiter G., Walker P.R., Lalive P.H. The neurotrophic hepatocyte growth factor attenuates CD8+ cytotoxic T-lymphocyte activity. J. Neuroinflamm. 2013;10:919. doi: 10.1186/1742-2094-10-154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-10-154</ArticleId><ArticleId IdType="pmc">PMC3881506</ArticleId><ArticleId IdType="pubmed">24344806</ArticleId></ArticleIdList></Reference><Reference><Citation>Tidball J.G. Regulation of muscle growth and regeneration by the immune system. Nat. Rev. Immunol. 2017;17:165&#x2013;178. doi: 10.1038/nri.2016.150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2016.150</ArticleId><ArticleId IdType="pmc">PMC5452982</ArticleId><ArticleId IdType="pubmed">28163303</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko K.R., Lee J., Lee D., Nho B., Kim S. Hepatocyte Growth Factor (HGF) Promotes Peripheral Nerve Regeneration by Activating Repair Schwann Cells. Sci. Rep. 2018;8:8316. doi: 10.1038/s41598-018-26704-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-26704-x</ArticleId><ArticleId IdType="pmc">PMC5973939</ArticleId><ArticleId IdType="pubmed">29844434</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X., Liu J., Zhao S., Zhang H., Cai W., Cai M., Ji X., Leak R.K., Gao Y., Chen J., et al. Interleukin-4 Is Essential for Microglia/Macrophage M2 Polarization and Long-Term Recovery After Cerebral Ischemia. Stroke. 2016;47:498&#x2013;504. doi: 10.1161/STROKEAHA.115.012079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.115.012079</ArticleId><ArticleId IdType="pmc">PMC4729613</ArticleId><ArticleId IdType="pubmed">26732561</ArticleId></ArticleIdList></Reference><Reference><Citation>Sironi F., Vallarola A., Violatto M.B., Talamini L., Freschi M., De Gioia R., Capelli C., Agostini A., Moscatelli D., Tortarolo M., et al. Multiple intracerebroventricular injections of human umbilical cord mesenchymal stem cells delay motor neurons loss but not disease progression of SOD1G93A mice. Stem Cell Res. 2017;25:166&#x2013;178. doi: 10.1016/j.scr.2017.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scr.2017.11.005</ArticleId><ArticleId IdType="pubmed">29154076</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi C., Cusimano M., Zambito M., Finardi A., Capotondo A., Garcia-Manteiga J.M., Comi G., Furlan R., Martino G., Muzio L. Interleukin 4 modulates microglia homeostasis and attenuates the early slowly progressive phase of amyotrophic lateral sclerosis. Cell Death Dis. 2018;9:1&#x2013;16. doi: 10.1038/s41419-018-0288-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-018-0288-4</ArticleId><ArticleId IdType="pmc">PMC5833860</ArticleId><ArticleId IdType="pubmed">29445154</ArticleId></ArticleIdList></Reference><Reference><Citation>Molnarfi N., Benkhoucha M., Funakoshi H., Nakamura T., Lalive P.H. Hepatocyte growth factor: A regulator of inflammation and autoimmunity. Autoimmun. Rev. 2015;14:293&#x2013;303. doi: 10.1016/j.autrev.2014.11.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2014.11.013</ArticleId><ArticleId IdType="pubmed">25476732</ArticleId></ArticleIdList></Reference><Reference><Citation>Coque E., Salsac C., Espinosa-Carrasco G., Varga B., Degauque N., Cadoux M., Crab&#xe9; R., Virenque A., Soulard C., Fierle J.K., et al. Cytotoxic CD8+ T lymphocytes expressing ALS-causing SOD1 mutant selectively trigger death of spinal motoneurons. Proc. Natl. Acad. Sci. USA. 2019;116:2312&#x2013;2317. doi: 10.1073/pnas.1815961116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1815961116</ArticleId><ArticleId IdType="pmc">PMC6369778</ArticleId><ArticleId IdType="pubmed">30674678</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers D.R., Henkel J.S., Zhao W., Wang J., Huang A., Wen S., Liao B., Appel S.H. Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis. Brain. 2011;134:1293&#x2013;1314. doi: 10.1093/brain/awr074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr074</ArticleId><ArticleId IdType="pmc">PMC3097891</ArticleId><ArticleId IdType="pubmed">21596768</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheean R.K., McKay F.C., Cretney E., Bye C.R., Perera N.D., Tomas D., Weston R.A., Scheller K.J., Djouma E., Menon P., et al. Association of Regulatory T-Cell Expansion With Progression of Amyotrophic Lateral Sclerosis: A Study of Humans and a Transgenic Mouse Model. JAMA Neurol. 2018;75:681&#x2013;689. doi: 10.1001/jamaneurol.2018.0035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2018.0035</ArticleId><ArticleId IdType="pmc">PMC5885208</ArticleId><ArticleId IdType="pubmed">29507931</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilangumaran S., Villalobos-Hernandez A., Bobbala D., Ramanathan S. The hepatocyte growth factor (HGF)&#x2013;MET receptor tyrosine kinase signaling pathway: Diverse roles in modulating immune cell functions. Cytokine. 2016;82:125&#x2013;139. doi: 10.1016/j.cyto.2015.12.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2015.12.013</ArticleId><ArticleId IdType="pubmed">26822708</ArticleId></ArticleIdList></Reference><Reference><Citation>Henkel J.S., Beers D.R., Sikl&#xf3;s L., Appel S.H. The chemokine MCP-1 and the dendritic and myeloid cells it attracts are increased in the mSOD1 mouse model of ALS. Mol. Cell Neurosci. 2006;31:427&#x2013;437. doi: 10.1016/j.mcn.2005.10.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2005.10.016</ArticleId><ArticleId IdType="pubmed">16337133</ArticleId></ArticleIdList></Reference><Reference><Citation>Malaspina A., Puentes F., Amor S. Disease origin and progression in amyotrophic lateral sclerosis: An immunology perspective. Int. Immunol. 2015;27:117&#x2013;129. doi: 10.1093/intimm/dxu099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxu099</ArticleId><ArticleId IdType="pubmed">25344935</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H.A., Lee J.D., Lee K.M., Woodruff T.M., Noakes P.G. Complement C5a-C5aR1 signalling drives skeletal muscle macrophage recruitment in the hSOD1G93A mouse model of amyotrophic lateral sclerosis. Skelet Muscle. 2017;7:10. doi: 10.1186/s13395-017-0128-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13395-017-0128-8</ArticleId><ArticleId IdType="pmc">PMC5455206</ArticleId><ArticleId IdType="pubmed">28571586</ArticleId></ArticleIdList></Reference><Reference><Citation>Lietha D. Crystal structures of NK1-heparin complexes reveal the basis for NK1 activity and enable engineering of potent agonists of the MET receptor. EMBO J. 2001;20:5543&#x2013;5555. doi: 10.1093/emboj/20.20.5543.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/20.20.5543</ArticleId><ArticleId IdType="pmc">PMC125671</ArticleId><ArticleId IdType="pubmed">11597998</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>